Characteristics and Treatment Patterns of Patients With Myasthenia Gravis: A Retrospective, Real-world Analysis of a United States Claims Database

Assessing Glucocorticoid Associated Toxicity in Myasthenia Gravis Using the Glucocorticoid Toxicity Index

Patient Satisfaction With Ravulizumab Treatment for Generalized Myasthenia Gravis (gMG) in the United States (US)

Rescue Treatment of Inebilizumab in Refractory Myasthenia Gravis: A Case Report

Use of Biologic Therapy in Seropositive Generalized Myasthenia Gravis in a Single Cohort